UnitedHealth Group Inc. (NYSE:UNH)

Goodwill and intangible assets exhibited a consistent upward trend over the five-year period. Significant fluctuations were observed within specific intangible asset categories, particularly trade names, trademarks, operating licenses and certificates and other indefinite-lived assets. Overall, the company’s investment in these assets increased substantially.

Goodwill

Goodwill increased steadily from US$75,795 million in 2021 to US$110,499 million in 2025, representing a cumulative increase of approximately 46%. The largest single-year increase occurred between 2022 and 2023, with an addition of US$10,380 million. Growth rates decelerated in the later years, with a smaller increase between 2024 and 2025.

Customer-related Intangibles

Customer-related intangibles increased from US$13,011 million in 2021 to US$16,303 million in 2022, and then to US$16,636 million in 2023. A further increase to US$17,190 million was observed in 2024, followed by a decrease to US$14,456 million in 2025. This represents the only significant decline within the major intangible asset categories during the period.

Trademarks and Technology

Trademarks and technology assets showed consistent growth, increasing from US$1,630 million in 2021 to US$2,917 million in 2024. However, a decrease to US$2,356 million was recorded in 2025, indicating a potential reversal of this trend.

Trade Names, Trademarks, Operating Licenses and Certificates and Other Indefinite-Lived Assets

This category experienced the most dramatic change. Starting at US$617 million in 2021, it rose sharply to US$10,454 million in 2024 before settling at US$10,734 million in 2025. The substantial increase in 2024 suggests a significant acquisition or internal investment in these types of assets.

Other Intangible Assets

The ‘Other’ category fluctuated, increasing from US$422 million in 2021 to US$1,176 million in 2022, then decreasing to US$400 million in 2025. This suggests potential volatility or specific, short-term investments within this grouping.

Other Intangible Assets – Net Carrying Value

The gross carrying value of other intangible assets increased from US$15,680 million in 2021 to US$31,618 million in 2024, before decreasing to US$27,946 million in 2025. Accumulated amortization increased consistently throughout the period, from -US$5,636 million in 2021 to -US$8,350 million in 2024, and then decreased slightly to -US$7,472 million in 2025. The net carrying value followed the trend of the gross carrying value, increasing from US$10,044 million in 2021 to US$23,268 million in 2024, and then decreasing to US$20,474 million in 2025.

Total Goodwill and Intangible Assets

The combined value of goodwill and intangible assets increased from US$85,839 million in 2021 to US$130,973 million in 2025. The rate of increase slowed in the final two years of the period, but the overall trend remained positive. The total value remained relatively stable between 2024 and 2025.

An examination of the financial information reveals significant adjustments made to both total assets and shareholders’ equity attributable to UnitedHealth Group between 2021 and 2025. These adjustments appear to stem from the removal of goodwill and intangible assets, resulting in substantially lower adjusted figures compared to those reported.

Total Assets

Reported total assets demonstrate a consistent upward trend, increasing from US$212,206 million in 2021 to US$309,581 million in 2025. However, the adjusted total assets, reflecting the removal of goodwill, present a different picture. While also increasing over the period, the growth is considerably slower, moving from US$136,411 million in 2021 to US$199,082 million in 2025. The difference between reported and adjusted total assets widens each year, indicating a growing amount of goodwill and intangibles on the balance sheet that are subsequently removed in the adjusted figures.

Shareholders’ Equity

Reported shareholders’ equity attributable to UnitedHealth Group shows a steady increase from US$71,760 million in 2021 to US$94,110 million in 2025. In contrast, the adjusted shareholders’ equity exhibits a negative trend, starting at a negative US$4,035 million in 2021 and declining to a negative US$16,389 million by 2025. This substantial negative adjustment to shareholders’ equity suggests a significant erosion of equity when goodwill and related intangible assets are excluded. The magnitude of the negative adjustment increases over time, mirroring the trend observed in the difference between reported and adjusted total assets.

The divergence between reported and adjusted figures highlights the considerable impact of goodwill and intangible assets on the company’s reported financial position. The negative adjusted shareholders’ equity raises concerns about the underlying economic reality of the equity position when these items are removed. The consistent widening gap between reported and adjusted total assets suggests an increasing reliance on goodwill and intangibles to support the reported asset base.

Further investigation into the nature and valuation of these goodwill and intangible assets would be necessary to fully understand the implications of these adjustments and assess the sustainability of the reported financial performance.

The financial metrics demonstrate a notable impact from adjusting for goodwill. Reported asset turnover remains relatively stable, fluctuating between 1.31 and 1.43 over the observed period. However, the adjusted total asset turnover consistently exhibits higher values, ranging from 2.09 to 2.23, and shows an increasing trend from 2021 to 2025.

Asset Turnover

The difference between reported and adjusted total asset turnover suggests that goodwill significantly depresses the reported efficiency of asset utilization. The increasing adjusted ratio indicates improving operational efficiency when goodwill is excluded from total assets.

Reported financial leverage shows a gradual increase from 2.96 in 2021 to 3.29 in 2025. Adjusted financial leverage values are not available for comparison.

Return on Equity (ROE)

Reported ROE experiences a peak in 2022 at 25.87%, followed by a substantial decline to 12.81% in 2025. The adjusted ROE, while not fully presented, is expected to reveal a different trend due to the exclusion of goodwill, which impacts net income attributable to common shareholders.

Reported Return on Assets (ROA) mirrors the trend in ROE, peaking at 8.19% in 2022 and declining to 3.89% in 2025. The adjusted ROA consistently shows higher values than the reported ROA, ranging from 12.67% to 6.06%, and also demonstrates a decreasing trend, though from a higher base.

Return on Assets (ROA)

The substantial difference between reported and adjusted ROA highlights the considerable impact of goodwill on profitability metrics. The decline in both reported and adjusted ROA suggests a weakening in the company’s ability to generate earnings from its assets, even when excluding the effect of goodwill. The adjusted ROA provides a clearer picture of core operational profitability.

Overall, the analysis indicates that goodwill has a material effect on key financial ratios. While reported ratios present a picture of declining profitability and stable asset turnover, the adjusted ratios suggest a more efficient use of assets and a potentially different profitability trajectory when goodwill is not considered.

An examination of the financial information reveals distinct trends in both total asset figures and associated turnover ratios over the five-year period. Reported total assets demonstrate a consistent upward trajectory, increasing from US$212,206 million in 2021 to US$309,581 million in 2025. However, adjusted total assets, which exclude goodwill and intangible assets, exhibit a more moderate growth pattern, rising from US$136,411 million to US$199,082 million during the same timeframe. This divergence suggests an increasing proportion of total assets are comprised of goodwill and intangible assets.

Reported Total Asset Turnover

The reported total asset turnover ratio remains relatively stable between 2021 and 2024, fluctuating between 1.31 and 1.34. A notable increase to 1.43 is observed in 2025, indicating improved efficiency in generating revenue from reported assets. This improvement could be attributed to increased sales volume or better asset utilization.

Adjusted Total Asset Turnover

The adjusted total asset turnover ratio, which focuses on tangible assets, displays a generally increasing trend. It rose from 2.09 in 2021 to 2.23 in 2025, with intermediate values of 2.11, 2.16, and 2.06 in 2022, 2023, and 2024 respectively. The ratio experienced a slight dip in 2024 before recovering strongly in 2025. This suggests that the company is becoming more efficient at generating sales from its core, tangible assets. The consistently higher adjusted turnover ratio compared to the reported ratio highlights the impact of goodwill and intangible assets on overall asset efficiency.

The difference between the reported and adjusted total asset turnover ratios widens over the period, particularly in the later years. This indicates that the revenue generated per dollar of goodwill and intangible assets is lower than that generated per dollar of tangible assets. While the increasing reported total asset turnover in 2025 is positive, the continued growth in the adjusted ratio suggests that operational efficiency improvements are primarily driven by better utilization of tangible assets rather than the value attributed to goodwill and intangibles.

Reported total assets increased steadily from $212.206 billion in 2021 to $309.581 billion in 2025. Concurrent with this growth in reported assets, reported shareholders’ equity attributable to UnitedHealth Group also exhibited an upward trend, rising from $71.760 billion to $94.110 billion over the same period. This resulted in a relatively stable, but slightly increasing, reported financial leverage ratio, moving from 2.96 in 2021 to 3.29 in 2025.

However, the adjusted figures present a significantly different picture. Adjusted total assets also increased over the period, though at a slower rate than reported total assets, reaching $199.082 billion in 2025. A notable feature of the adjusted figures is the consistently negative adjusted shareholders’ equity attributable to UnitedHealth Group, ranging from -$4.035 billion in 2021 to -$16.389 billion in 2025. This negative equity position is a key driver of the missing adjusted financial leverage values.

Adjusted Shareholders’ Equity

Adjusted shareholders’ equity attributable to UnitedHealth Group began as a small negative value in 2021, but deteriorated substantially, becoming increasingly negative through 2025. This suggests a significant reduction in equity when accounting for adjustments to the reported figures. The magnitude of the negative equity is concerning and warrants further investigation into the nature of these adjustments.

Adjusted Financial Leverage

Due to the negative adjusted shareholders’ equity, the adjusted financial leverage ratio cannot be meaningfully calculated for any of the years presented. Financial leverage is typically calculated as total assets divided by shareholders’ equity. With a negative denominator, the resulting ratio is undefined or misleading. The absence of this metric limits the ability to assess the company’s risk profile based on adjusted figures.

The divergence between reported and adjusted figures highlights the impact of specific adjustments made to the balance sheet. The increasing negative adjusted shareholders’ equity suggests that these adjustments primarily affect the equity portion of the balance sheet, potentially related to items such as accumulated other comprehensive income, intangible assets, or goodwill. Further analysis is needed to understand the specific nature of these adjustments and their implications for the company’s financial health.

Shareholders’ equity attributable to UnitedHealth Group exhibited a consistent increase from 2021 through 2025. Reported shareholders’ equity rose from US$71,760 million in 2021 to US$94,110 million in 2025. However, adjusted shareholders’ equity presents a contrasting picture, beginning with a negative value of US$-4,035 million in 2021 and becoming increasingly negative, reaching US$-16,389 million by 2025.

Reported Return on Equity (ROE)

Reported ROE demonstrated growth from 2021 to 2022, increasing from 24.09% to 25.87%. A slight decrease was observed in 2023, with ROE at 25.22%. A significant decline in reported ROE occurred in 2024, falling to 15.55%, and continued downward in 2025 to 12.81%.

The substantial difference between reported and adjusted shareholders’ equity suggests the presence of significant adjustments being made to the reported equity figure. The increasing negative value of adjusted shareholders’ equity indicates that these adjustments are becoming more substantial over time. This could be due to various factors, such as the amortization of intangible assets or changes in valuation allowances. The decline in reported ROE from 2023 to 2025 coincides with the increasing negative trend in adjusted shareholders’ equity, suggesting a correlation between these two metrics.

Adjusted Return on Equity (ROE)

Values for adjusted ROE are not available for any of the periods presented. Without this information, it is impossible to assess the impact of the adjustments to shareholders’ equity on the company’s profitability as measured by ROE. The absence of adjusted ROE values limits a comprehensive understanding of the underlying economic performance.

The trend in reported ROE, while initially positive, reveals a considerable decrease in later years. The lack of adjusted ROE figures prevents a full assessment of the impact of the equity adjustments on the company’s true profitability. Further investigation into the nature of the adjustments to shareholders’ equity is warranted to understand the drivers behind these changes and their implications for the company’s financial health.

An examination of the financial information reveals distinct trends in both reported and adjusted asset bases, and their corresponding returns. Total assets, as reported, demonstrate a consistent increase from 2021 through 2025. However, adjusted total assets, which excludes goodwill and intangible assets, exhibits a more moderate growth pattern. This difference in growth rates impacts the observed return on assets.

Reported Return on Assets (ROA)

Reported ROA remained relatively stable between 2021 and 2023, fluctuating around 8.15% to 8.19%. A significant decline is then observed in 2024, falling to 4.83%, and continues to decrease in 2025, reaching 3.89%. This downward trend suggests diminishing profitability relative to the reported total asset base.

Adjusted Return on Assets (ROA)

Adjusted ROA consistently exceeds reported ROA across all periods. It also shows a similar pattern of decline, though less pronounced. Adjusted ROA increased from 12.67% in 2021 to 13.21% in 2022, then remained relatively stable around 13.17% in 2023. A decrease to 7.52% is noted in 2024, followed by a further reduction to 6.06% in 2025. The adjusted ROA trend indicates that core operational profitability, excluding the impact of goodwill and intangibles, is also experiencing a decline, but at a slower pace than the reported ROA.

The divergence between reported and adjusted ROA highlights the substantial contribution of goodwill and intangible assets to the reported asset base. The decreasing ROA figures, both reported and adjusted, warrant further investigation into the underlying drivers of profitability. The slower decline in adjusted ROA suggests that the decrease in profitability is not solely attributable to the impact of goodwill and intangible assets, but also reflects changes in core operational performance.

Asset Base Composition

The difference between reported and adjusted total assets widens over the period, indicating a growing proportion of goodwill and intangible assets relative to the total asset base. In 2021, adjusted assets represented approximately 64.2% of reported assets, while in 2025, this figure decreased to approximately 64.4%. This suggests a continued reliance on these non-tangible assets.

The observed trends suggest a potential need to evaluate the performance of acquired businesses and the value of intangible assets. Continued monitoring of these ratios is recommended to assess the sustainability of profitability and the effectiveness of capital allocation.